Document Detail

Coronary Artery Disease Potentiates Response to Dofetilide for Rhythm Control of Atrial Fibrillation.
MedLine Citation:
PMID:  22017595     Owner:  NLM     Status:  Publisher    
Background: Dofetilide, a class III antiarrhythmic, is one of the few alternatives to amiodarone in patients with atrial fibrillation (AF) and heart failure or coronary artery disease (CAD). While amiodarone has been extensively studied, little is known about predictors of response to dofetilide. We sought to identify clinical parameters associated with dofetilide success in a large cohort of patients with AF. Methods/Results: A total of 287 patients with AF started on dofetilide between 2001 and 2008 were included. Dofetilide was deemed "completely effective" if the patient remained on dofetilide at follow-up and had no recurrences of AF clinically or by electrocardiogram. Dofetilide efficacy was analyzed in relation to clinical variables relevant to AF and AF recurrence. After a follow-up of 10.2 ± 7.7 months, 54.7% of the patients remained on dofetilide and it was completely effective in 26.8%. The discontinuation rate during initial hospitalization was 13.3% from excessive QT prolongation and one patient with torsades de pointes (successfully treated). A history of CAD was the only univariate predictor of efficacy (odds ratio [OR] 2.27, 95% confidence interval [CI] 1.29-4.01, P < 0.05). CAD remained the only significant factor associated with efficacy of dofetilide in a multivariate regression model (OR 2.01, 95% CI 1.11-3.70, P < 0.05, n = 270). The overall efficacy of dofetilide in patients with CAD was 41.1%, compared to 23.5% in those without CAD (P < 0.05). Conclusions: In this large cohort of patients with AF, underlying coronary disease was significantly associated with dofetilide success. This finding may have utility for clinical decisions regarding initiation of dofetilide. (PACE 2011; 1-4).
Pankaj Manocha; Venkata Bavikati; Jonathan Langberg; Michael S Lloyd
Related Documents :
22729595 - Is endoscopic ultrasound needed as an add-on test for gallstone diseases without choled...
22675855 - Characterization of movement disorders in patients with familial creutzfeldt-jakob dise...
21840625 - Do signs of natural plugging of superior semicircular canal dehiscence exist?
22332135 - Cystic fibrosis transmembrane conductance regulator gene abnormalities in patients with...
19132425 - Accuracy of ct angiography for the diagnosis of vascular abnormalities causing intrapar...
22729595 - Is endoscopic ultrasound needed as an add-on test for gallstone diseases without choled...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-20
Journal Detail:
Title:  Pacing and clinical electrophysiology : PACE     Volume:  -     ISSN:  1540-8159     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7803944     Medline TA:  Pacing Clin Electrophysiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
©2011, The Authors. Journal compilation ©2011 Wiley Periodicals, Inc.
Department of Cardiac Electrophysiology, Emory University Hospital, Atlanta, Georgia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Plasma Indoleamine 2,3-Dioxygenase Concentration is Increased in Hemodialysis Patients and May Contr...
Next Document:  Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina....